An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

We recently compiled a list of the 10 Firms Fall Amid Disappointing Earnings Performance. In this article, we are going to ...

It has been almost five years since the COVID-19 pandemic happened and close to two years since President Marcos lifted the public health emergency in the country. And yet, costly irregularities, ...

It has been almost five years since the COVID-19 pandemic happened and yet, costly irregularities, shortcomings and missteps surrounding the Duterte era COVID-19 pandemic response continue to rear ...

Kennedy, who has faced opposition from health groups and Democrats, has long sown doubts about the safety and efficacy of ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

High vaccine wastage and low vaccination and booster rates marred the government’s P74.68-million COVID-19 National ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...